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A B S T R A C T
Background: Phenol exposure during pregnancy has been associated with preterm birth, but the potential effect
of preconception exposure in either parent is unknown. There is a growing body of evidence to suggest that the
preconception period is a critical window of vulnerability for adverse pregnancy outcomes.
Objective: We examined whether maternal and paternal preconception urinary concentrations of select phenols
were associated with the risk of preterm birth among couples attending fertility care.
Methods: The analysis included 417 female and 229 male participants of the Environment and Reproductive
Health (EARTH) Study who gave birth to 418 singleton infants between 2005 and 2018 and for whom we had
phenol biomarkers quantified in at least one urine sample collected before conception. Mothers and fathers
provided an average of 4 and 3 urine samples during the preconception period, respectively. We calculated the
geometric mean of bisphenol A (BPA), bisphenol S (BPS), benzophenone-3, triclosan, and the molar sum of
parabens (ΣParabens) urinary concentrations to estimate each participant’s preconception exposure. Risk ratios
(RRs) of preterm birth (live birth before 37 completed weeks’ gestation) were estimated using modified Poisson
regression models adjusted for covariates.
Results: The mean (SD) gestational age among singletons was 39.3 (1.7) weeks with 8% born preterm. A natural
log-unit increase in maternal preconception BPA (RR 1.94; 95% CI: 1.20, 3.14) and BPS (RR 2.42; 95% CI: 1.01,
5.77) concentration was associated with an increased risk of preterm birth. These associations remained after
further adjustment for maternal prenatal and paternal preconception biomarker concentrations. Paternal pre-
conception ΣParabens concentrations showed a possible elevated risk of preterm birth (RR 1.36; 95% CI: 0.94,
1.96). No consistent pattern of association was observed for benzophenone-3 or triclosan biomarkers in either
parent.
Discussion: Maternal preconception urinary BPA and BPS concentrations, as well as paternal preconception
urinary parabens concentrations were prospectively associated with a higher risk of preterm birth. Subfertile
couples’ exposure to select phenols during the preconception period may be an unrecognized risk factor for
adverse pregnancy outcomes.
1. Introduction
Preterm birth is a leading cause of perinatal and infant morbidity
worldwide (Romero et al., 2014; Rubens et al., 2014) and is a relatively
common perinatal outcome with around one in ten babies born with
this condition in Europe and in the United States (U.S.)
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(Chawanpaiboon et al., 2019; EFCNI, 2010; WHO, 2012). Prenatal ex-
posure to endocrine disrupting chemicals (EDCs) is considered a po-
tential risk factor for preterm birth (Ferguson and Chin, 2017; Porpora
et al., 2019). EDCs are exogenous chemicals that can interfere with any
aspect of hormone action (Zoeller et al., 2012). Phenolic EDCs are of
particular concern, as human exposure is ubiquitous and occurs
through diet, use of personal care products, and multiple other lifestyle-
related sources (Frederiksen et al., 2014; Freire et al., 2019; Messerlian
et al., 2017).
Bisphenol A (BPA) is a paradigmatic EDC that disrupts hormonal
homeostasis at low doses in experimental studies (Vandenberg et al.,
2012), and is classified as an ovarian and reproductive toxicant (ECHA,
2016; Peretz et al., 2014). Despite this, BPA is extensively used in the
manufacturing of polycarbonate plastics, epoxy resins liners of canned
food, and thermal paper, among numerous other applications
(Mustieles et al., 2015; Vandenberg et al., 2007; von Goetz et al., 2017).
Increasing public concern over BPA has led to its replacement in some
consumer products often labeled as “BPA-free.” However, most re-
placements are structural analogs such as bisphenol S (BPS), which are
also hormonally active (Rochester and Bolden, 2015) and are suspected
of having similar adverse effects in experimental animals (Carvaillo
et al., 2019). BPA to BPS replacement is a concern in many countries
(Kataria et al., 2017; Molina-Molina et al., 2019; Ye et al., 2015), with
the speed of substitution being relatively faster in the United States
market compared to other countries (Wu et al., 2018). Other phenolic
EDCs such as parabens and triclosan are frequently used in personal
care products, food additives, and pharmaceuticals to prevent microbial
growth (Ferguson et al., 2017; Giulivo et al., 2016), while benzophe-
none-3 is used as an ultraviolet filter in sunscreens, body lotions, and
make-up, among other uses (Liao and Kannan, 2014). Despite concern
about the potential endocrine action of these phenols (Ghazipura et al.,
2017; Johnson et al., 2016; Nowak et al., 2018), epidemiologic evi-
dence on birth outcomes is limited (Giulivo et al., 2016; Jamal et al.,
2019; Messerlian et al., 2018a).
New and emerging data highlights the potential for EDCs to exert
enduring epigenetic modifications in male and female gametes, as well
as in other female reproductive organs (Luderer et al., 2019; Santangeli
et al., 2017; Xin et al., 2015; Zama and Uzumcu, 2010). Further, epi-
genetic modifications likely contribute to preterm birth etiology (Mani
et al., 2018; Menon et al., 2012) and have been recently identified as a
key characteristic of female reproductive toxicants (Luderer et al.,
2019). The preconception period is thus increasingly recognized as a
highly sensitive window for environmental perturbation, via both ma-
ternal and paternal exposures (Braun et al., 2017; Toivonen et al.,
2017). However, while some epidemiologic studies have previously
explored the relationship between prenatal exposure to phenols and the
risk of delivering preterm (Aung et al., 2019; Behnia et al., 2016;
Cantonwine et al., 2010, 2015; Huo et al., 2018), the impact of pre-
conception EDC exposures on preterm birth constitutes a knowledge
gap (Toivonen et al., 2017). Therefore, our objective was to examine
whether maternal and paternal urinary phenol biomarker concentra-
tions measured before conception were associated with preterm birth in




The Environment and Reproductive Health (EARTH) Study is an
ongoing prospective preconception cohort of couples from the
Massachusetts General Hospital (MGH) Fertility Center. The EARTH
Study aims to investigate how environmental and nutritional factors in
both males and females from preconception throughout pregnancy in-
fluence fertility, gestation, and birth outcomes. The cohort has been
previously described in detail (Messerlian et al., 2018b). Briefly,
women 18–46 and men 18–55 years of age are invited to enroll in-
dependently or as a couple, and are followed from study entry
throughout their fertility care, pregnancy, and labor and delivery.
Participants complete general and lifestyle questionnaires, undergo
anthropometric measurements, and provide a spot urine and blood
sample at baseline and then subsequently during each fertility treat-
ment cycle, as well as across trimesters among those females achieving
pregnancy.
The present study included 417 female and 229 male EARTH cohort
participants who gave birth to a singleton infant between 2005 and
2018 and for whom we quantified phenol biomarkers in at least one
urine sample collected before conception of the index pregnancy. One
male participant enrolled without a female partner and had a singleton
live birth, thus leaving 228 couples. Among the 418 singleton infants,
preconception BPA measurements were available for 417 mother–child
pairs and 229 father-child pairs, and paraben concentrations were
available for 405 mother–child and 223 father-child pairs.
Measurement of benzophenone-3 and triclosan began in 2010; pre-
conception urinary concentrations were available for 278 mother–child
pairs and 139 father-child pairs. Measurement of BPS did not begin
until 2012; urinary concentrations were available for 163 mother–child
pairs and 77 father–child pairs (See Fig. 1, Participant Flow Chart).
Trained study staff explained the study details to all participants and
answered any questions before obtaining their signed informed consent.
The study was approved by the Institutional Review Boards of MGH,
Harvard T.H. Chan School of Public Health, and the Centers for Disease
Control and Prevention (CDC).
2.2. Exposure assessment
Male and female participants provided one spot urine sample at
study entry. Females provided up to two additional spot urine samples
per fertility treatment cycle: the first sample collected during the fol-
licular phase of the cycle (days 3 to 9) and the second obtained on the
day of the fertility procedure [at time of oocyte retrieval, or embryo
transfer for fresh or frozen in-vitro fertilization (IVF) treatment, or on
the day of intrauterine insemination (IUI)]. During pregnancy, women
also provided one spot urine sample per trimester at median 6, 21, and
35 weeks’ gestation. Males provided an additional spot urine sample per
cycle on the day when their female partner underwent the fertility
procedure. We used multiple urine samples per participant obtained
from study entry up to and including the samples from the cycle of
conception of the index pregnancy to estimate mean exposure in the
preconception window.
Urine was collected in a polypropylene specimen cup and analyzed
for specific gravity (SG) with a handheld refractometer (National
Instrument Company, Inc., Baltimore, MD, USA), divided into aliquots,
and frozen for long-term storage at −80 °C. All samples were shipped
on dry ice overnight to the CDC (Atlanta, GA, USA) for quantification of
urinary phenol concentrations using solid phase extraction coupled
with high performance liquid chromatography-isotope dilution tandem
mass spectrometry (Zhou et al., 2014). The urinary concentrations of
the following phenols were measured: BPA, BPS, methylparaben,
ethylparaben, propylparaben, butylparaben, benzophenone-3 and tri-
closan. The limits of detection (LOD) ranged from 0.1 to 1.0 ng/ml.
Concentrations below the LOD were assigned the LOD divided by the
square root of two (Hornung, 1990). Due to low detection frequencies
and small number of participants with ethylparaben quantified, we did
not include or consider ethylparaben in further analyses. The weighted
molar sum of parabens was calculated by dividing each urinary con-
centration by its molecular weight and then summing: ∑Para-
bens = [(Methylparaben * (1/152.15 g/mol)) + (Propylparaben * (1/
180.20 g/mol)) + (Butylparaben * (1/194.23 g/mol))]. We then
weighted this sum by the molecular weight of methylparaben (152.15
g/mol) to convert the molar concentration to units of ng/mL.
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2.3. Outcome assessment
Gestational age in days was abstracted from delivery records and
validated using the American College of Obstetricians and
Gynecologists (ACOG) guidelines to estimate gestational age for births
following medically assisted reproduction (ACOG, 2014). The fertility
treatment setting permitted us to estimate gestational age with high
accuracy using in vitro fertilization (IVF) embryo transfer dates, sub-
stantially reducing misclassification of preterm birth due to in-
accuracies in pregnancy dating (Savitz et al., 2002). For IVF pregnan-
cies, gestational age was estimated as (outcome date – embryo transfer
date + 14 days + cycle day of transfer) (ACOG, 2014). For IUI and
non-medically assisted/naturally conceived pregnancies, we used birth
date minus cycle start date. Gestational age was corrected if medical
delivery record estimates (gold standard) differed by over 6 days from
the estimated gestational age using the described methods (corrected
for three infants through additional chart verification). Preterm birth
was defined as any live birth prior to 37 weeks of completed gestation
(< 259 days).
2.4. Covariates
At study entry, paternal and maternal age, education, race, and
smoking status were obtained from self-reported questionnaires. A re-
search study staff measured the height and weight of participants, and
Body Mass Index (BMI) (kg/m2) was calculated. The physician admin-
istering fertility treatment diagnosed any underlying cause of infertility
using the Society for Assisted Reproductive Technology (ART) defini-
tions. Type of medically assisted reproduction used in the conception
cycle of the index birth was abstracted from the electronic medical
records by trained study staff and dichotomized: ART procedures (e.g.,
stimulated IVF cycles with fresh embryo transfers or cryo-thawed em-
bryo transfer protocols) versus non-ART protocols (e.g., IUI with or
without ovulation induction/stimulation; ovulation induction/stimula-
tion with timed intercourse, or non-medically assisted/naturally con-
ceived).
2.5. Statistical analysis
To account for urinary dilution, we adjusted concentrations by
multiplying each biomarker concentration by [(SGp-1)/(SGi-1)], where
SGi is the SG of the participant’s urine sample and SGp is the mean SG
for all male (mean = 1.016) or all female (mean = 1.015) participants
included in the study samples (Pearson et al., 2009). The SG-adjusted
biomarker concentrations were natural log-transformed to standardize
the distribution and reduce the influence of extreme values. We esti-
mated geometric mean paternal and maternal preconception phenol
biomarker concentrations by averaging each participant’s log con-
centration obtained from all urine samples collected from study entry
and at each treatment cycle up to and including the cycle of the index
conception of the singleton.
We calculated descriptive statistics for biomarker concentrations
using SG-adjusted log concentrations, percentage of values below the
LOD, as well as Spearman correlation coefficients for log concentrations
between couples (paternal versus maternal preconception and across
preconception and prenatal windows). We described the clinical and
demographic characteristics of the study population with means
(standard deviation (SD)) or proportions (n, %). We fit modified
Poisson regression models to evaluate the association of continuous
urinary biomarker concentrations and dichotomous preterm birth out-
comes. Models were fit using a log link function and Poisson distribu-
tion to yield estimated risk ratios (RRs) and 95% confidence intervals
(CIs) for preterm birth for every natural log-unit increase in biomarker
concentration. We fit a separate model for each individual phenol
biomarker.
We selected a priori covariates as potential confounders based on
substantive knowledge using a directed acyclic graph (DAG, see Fig. 2)
(Textor et al., 2016) and examined unadjusted and covariate-adjusted
models. Models evaluating maternal preconception exposure were ad-
justed for: maternal age and BMI (continuous), maternal education
(< college, college, graduate degree), smoking status (never smoked
versus ever smoked, defined as a current or former smoker), and ART
vs. non-ART-based treatment. Both paternal and maternal covariates in
reproductive epidemiologic studies are increasingly considered in
confounding models (Bellavia et al., 2019). The study of paternal pre-
conception exposure is still a novel field; we thus chose to be more
conservative in models of father’s exposure. Paternal models were
therefore adjusted for both the maternal covariates presented in our
DAG in Fig. 2, as well as for father’s age (continuous), BMI (con-
tinuous), and smoking (never vs. ever). We also adjusted for partner’s
Fig. 1. Participant flow-chart and phenol biomarker data available in the EARTH Study 2005–2018. Abbreviations: bisphenol A (BPA); bisphenol S (BPS); benzo-
phenone 3 (BP-3); triclosan (TCS). * Note: One male participant joined without female partner, leaving 228 couples.
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preconception exposure in subsequent models. To account for potential
confounding by pregnancy-related exposure, we adjusted for mean
prenatal log-concentrations across three trimesters for the biomarker of
interest in additional multivariable models. Statistical analyses were
conducted with SAS (version 9.4; SAS Institute Inc., Cary, USA).
2.6. Sensitivity analyses
To explore potential dose–response associations within positive
findings, we created and fit models across biomarker quartiles. Given
that the placenta shows sex-dependent functions susceptible to en-
vironmental insults (Rosenfeld, 2015), and previous sex-specific asso-
ciations have been reported between prenatal phenol exposure and
preterm birth (Aker et al., 2019; Cantonwine et al., 2015), we stratified
analyses by infant sex and estimated sex-specific risk ratios and 95% CIs
(Buckley et al., 2017). We calculated effect-measure modification p-
values for the interaction term (sex × urine phenol biomarker con-
centration) and considered < 0.20 as potential evidence of effect
modification by infant sex on the multiplicative scale. In a previous
study, we found a downward trend in preconception BPA concentra-
tions among EARTH participants starting in 2012 up to 2018 (Mínguez-
Alarcón et al., 2019). As such, we chose to further adjust for study
period (≤2011 vs. ≥ 2012) in our maternal and paternal preconception
BPA models. Furthermore, because the number of completed fertility
cycles may influence both the number of urine samples collected for
estimating exposure as well as adverse birth outcomes, we included a
sensitivity analysis additionally adjusting for the number of fertility
cycles in order to test the robustness of the main findings.
3. Results
3.1. Study cohort
Our cohort included 417 mothers and 229 fathers (228 couples)
with an average age of 34.7 and 36.0 years and a mean BMI of 24.1 and
27.7 at recruitment, respectively (Table 1). Among the 418 singleton
infants, mean gestational age was 39.3 (SD = 1.7) weeks, with 8.1%
(n = 34) of infants born preterm (Table 2). Mean birth weight was
3360 (SD = 550) grams, with 4.8% (n = 20) of infants born low birth
weight (< 2500 g) (Table 2).
3.2. Urinary phenol concentrations
In total, 1693 maternal preconception and 547 paternal pre-
conception urine samples were quantified for phenol biomarkers.
Women and men provided on average 4.0 (range: 1–20) and 2.6 (range:
1–10) urine samples, respectively. Table S1 presents the distribution of
SG normalized mean urinary phenol biomarker concentrations. Within
the measured phenols, the geometric mean of the SG-adjusted urinary
concentrations for fathers and mothers were respectively: 1.4 and
1.1 ng/ml for BPA; 0.48 and 0.48 ng/ml for BPS; 30.7 and 142.9 ng/ml
Fig. 2. Hypothesized directed acyclic graph (DAG) between preconception
exposure to phenols and preterm birth risk. Abbreviations: body mass index
(BMI); assisted reproductive technology (ART).
Table 1
Parental characteristics from 417 women and 229 men participating in the
Environment and Reproductive Health (EARTH) Study (2005–2018).
Parental Characteristic Mothers Fathers
N = 417 N = 229
Age (years)
Mean ± SD 34.7 ± 4.0 36.0 ± 4.6
Age > 35, n (%) 172 (41) 127 (55)
Race, n (%)
White 353 (85) 201 (88)
Black 11 (3) 4 (2)
Asian 36 (8) 15 (6)
Other 17 (4) 9 (4)
Body Mass Index (BMI, Kg/m2)
Mean ± SD 24.1 ± 4.3 27.7 ± 6.1
BMI > 25, n (%) 132 (32) 156 (68)
Education, n (%)
< College 54 (13) 31 (17)
College Graduate 135 (32) 62 (34)
Graduate Degree 228 (55) 87 (49)
Smoking Status, n (%)
Never 314 (75) 159 (69)
Ever (former or current) 103 (25) 70 (31)
Infertility Diagnosis, n (%)
Male Factor 100 (24) 69 (30)
Female Factor 132 (32) 65 (28)
Unexplained 185 (44) 95 (42)
Primiparous, n (%) 346 (83) –
Table 2
Birth characteristics of 418 singletons from the Environment and
Reproductive Health (EARTH) Study (2005–2018).
Child Characteristics Births 2005–2018
N = 418
Male, n (%) 216 (52)
Birth weight (grams)
Mean ± SD 3360 ± 550
min–max 1090–5040
Low birth weight
< 2500 g, n (%) 20 (4.8)
Gestational age at birth
Mean weeks ± SD 39.3 ± 1.7
min–max 29–42
Mean days ± SD 275 ± 12.0
min–max 205–294
Preterm birth
< 37 weeks, n (%) 34 (8.1)
Mode of conception, n (%)
ART a 236 (56)
Non-ART b 182 (44)
a Assisted Reproductive Technology (ART): fresh or frozen in-vitro
fertilization protocols, including intracytoplasmic sperm injection.
b Non-ART: intrauterine insemination with or without ovulation
induction/stimulation; ovulation induction/stimulation with timed
intercourse, or non-medically assisted/naturally conceived.
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for ΣParabens; 63.4 and 161 ng/ml for benzophenone-3; and 14.6 ng/
ml and 14.0 ng/ml for triclosan (Table S1). The frequency of detection
was lowest for paternal preconception butylparaben (25.8%). The re-
maining paternal and maternal preconception phenol concentrations
had moderate to high detection frequencies ranging from 63.2% to
99.7% (Table S1). The lowest Spearman correlation coefficients were
observed for maternal and paternal preconception BPS concentrations
(r = 0.09) and maternal preconception and prenatal BPS concentra-
tions (r = 0.15). Other biomarkers presented moderate correlations for
maternal and paternal preconception concentrations (r = 0.23–0.59)
and maternal preconception and prenatal concentrations
(r = 0.27–0.60) (Table S2).
3.3. Maternal preconception window
Covariate-adjusted models showed a positive association between
maternal preconception urinary BPA concentrations and the risk of
preterm birth (RR 1.94; 95% CI: 1.20, 3.14). This association was
strengthened slightly in models additionally adjusted for maternal
prenatal BPA concentrations (RR 2.20; 95% CI: 1.29, 3.75), and re-
mained in models further adjusted for paternal BPA concentrations (RR
2.00; 95% CI: 1.00, 3.99) (Table 3). Sensitivity analyses revealed a
linear trend across quartiles of maternal preconception BPA con-
centrations and preterm birth risk (P test for trend = 0.01) (Table S3).
No significant difference was observed between male and female in-
fants in the association of maternal preconception BPA concentration
and preterm birth (P value for sex interaction term = 0.32) (Table S5).
Further adjustment for study period and number of fertility cycles did
not materially change the association between maternal preconception
BPA concentrations and preterm birth (RR 1.76; 95% CI: 1.02, 3.02)
(Table S6).
We also observed that higher maternal preconception urinary BPS
concentrations were associated with an elevated risk of preterm birth in
the covariate-adjusted model (RR 2.42; 95% CI: 1.01, 5.77), with a si-
milar pattern of strengthened associations after further adjustment for
maternal prenatal BPS concentrations (RR 3.33; 95% CI: 1.13, 8.80)
(Table 3). No differences by infant sex were observed with BPS (P value
for sex interaction term = 0.68) (Table S5). The positive association
between maternal preconception BPS and preterm birth remained after
adjusting for number of fertility cycles (RR 2.61; 95% CI: 1.03, 6.57)
(Table S6). Although mothers with higher preconception urinary tri-
closan concentrations had lower preterm birth risk (RR 0.78; 95% CI:
0.59, 1.04), confidence intervals became more imprecise after controlling
for prenatal triclosan (RR 0.78; 95% CI: 0.53, 1.14) (Table 3). No con-
sistent pattern of association compatible with the data was observed for
maternal preconception ∑Parabens or benzophenone-3 concentrations
(Table 3). In sex-stratified analyses, maternal preconception ∑Parabens
concentrations were associated with preterm birth among female but not
male infants (P value for sex interaction term = 0.13, Table S5).
3.4. Paternal preconception window
No association with preterm birth was observed for paternal pre-
conception urinary BPA concentrations (RR 0.82; 95% CI: 0.43, 1.55),
BPS (RR 0.49; 95% CI: 0.08, 2.98), benzophenone-3 (RR 1.02; 95% CI:
0.53, 1.99) or triclosan (RR 0.97; 95% CI: 0.67, 1.41) (Table 4). Fathers
with higher urinary concentrations of ΣParabens had singletons with a
higher but imprecise risk of preterm birth in the main covariate-ad-
justed model (RR 1.36; 95% CI: 0.94, 1.96). This was unchanged with
further adjustment for maternal preconception (RR 1.42; 95% CI: 0.97,
2.09) or pregnancy ΣParabens concentrations (RR 1.39; 95% CI: 0.95,
2.04) (Table 4). Further adjustment for number of fertility cycles did
Table 3
Risk Ratios (RR) and 95% Confidence Intervals (95% Cis) for preterm birth (< 37 weeks) per natural log-unit increase in maternal preconception urinary phenol














Covariates + Paternal Precon d
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
Bisphenol A
1.95 (1.23, 3.09) 1.94 (1.20, 3.14) 2.20 (1.29, 3.75) 2.00 (1.00, 3.99)
p-values 0.005 0.007 0.004 0.05
Preterm Birth n/N 34/417 34/417 31/384 18/228
Bisphenol S
2.31 (1.04, 5.14) 2.42 (1.01, 5.77) 3.33 (1.13, 8.80) DNC
p-values 0.04 0.05 0.03
Preterm Birth n/N 9/163 9/163 7/145 2/74
∑Parabense
0.99 (0.76, 1.29) 0.99 (0.76, 1.30) 0.90 (0.63, 1.29) 1.00 (0.65, 1.54)
p-values 0.93 0.95 0.57 0.99
Preterm Birth n/N 33/405 33/405 30/372 17/221
Benzophenone-3
0.91 (0.70, 1.19) 0.91 (0.68, 1.22) 0.93 (0.63, 1.39) 1.55 (0.89, 2.70)
p-values 0.50 0.53 0.74 0.12
Preterm Birth n/N 21/278 21/278 18/254 8/137
Triclosan
0.77 (0.58, 1.02) 0.78 (0.59, 1.04) 0.78 (0.53, 1.14) 1.16 (0.68, 1.97)
p-values 0.07 0.10 0.19 0.59
Preterm Birth n/N 21/278 21/278 18/254 8/137
Note: n, number of preterm birth cases; N, sample size for maternal preconception biomarker concentrations; DNC, did not converge.
a Models 1: Unadjusted.
b Models 2: Adjusted for age (continuous), BMI (continuous), ART (yes/no), smoking (ever/never), education (categorical).
c Models 3: Adjusted for age (continuous), BMI (continuous), ART (yes/no), smoking (ever/never), education (categorical) + prenatal biomarker exposure
(continuous log-concentration).
d Models 4: Adjusted for age (continuous), BMI (continuous), ART (yes/no), smoking (ever/never), education (categorical) + paternal preconception biomarker
exposure (continuous log-concentration).
e ΣParabens: the molar sum of parabens was estimated by dividing each concentration by its molecular weight and then summing: ∑Parabens = [(Methylparaben
* (1/152.15)) + Propylparaben * (1/180.20)) + Butylparaben * (1/194.23))]. We then weighted this sum by the molecular weight of methylparaben (152.15) to
convert the molar concentration to units of ng/ml.
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not materially change the association (RR 1.34; 95% CI: 0.93,1.93)
(Table S7). An examination of the individual parabens revealed that
higher paternal preconception concentrations of methylparaben (RR
1.35; 95% CI: 0.93, 1.98) and propylparaben (RR 1.27; 95% CI: 0.98,
1.65) were associated with a higher risk of preterm birth in covariate-
adjusted models (Table S4). The associations between paternal pre-
conception ΣParabens, methylparaben or propylparaben concentrations
and preterm birth did not differ by infant sex (Table S5).
4. Discussion
In this prospective study of couples seeking fertility care, maternal –
but not paternal – preconception BPA and BPS concentrations were
both associated with an elevated risk of singleton preterm birth. These
associations remained relatively unchanged after accounting for ma-
ternal prenatal or paternal preconception urinary BPA or BPS con-
centrations, suggesting that the maternal preconception period may be
a sensitive but underexplored critical window of exposure to bi-
sphenols. Although imprecise, paternal urinary paraben concentrations
were also associated with an increased risk of early birth. We observed
few differences by infant sex, however, small sample sizes within strata
may have precluded our ability to detect sex-specific associations. To
our knowledge, this is the first work that has assessed couples’ pre-
conception exposure to select phenols in relation to preterm birth.
Two previous maternal prenatal case-control studies have been
conducted in the United States; one reporting that third trimester ur-
inary BPA concentrations were positively associated with spontaneous
preterm birth, but not all types of preterm birth (Cantonwine et al.,
2015), and the other reporting higher maternal plasma BPA con-
centrations in mothers delivering preterm compared to women in term
labor (Behnia et al., 2016). Additionally, a recent analysis in the same
population studied by Cantonwine et al. (2015) observed an increased
risk of spontaneous preterm delivery in relation to higher maternal
urinary BPS concentrations measured during late pregnancy (Aung
et al., 2019). In contrast, a study among Chinese pregnant women who
provided a spot urine sample immediately after being admitted into
hospital for delivery reported inverse associations between urinary BPS
concentrations and pregnancy duration (Wan et al., 2018). Never-
theless, the limitations of the study by Wan et al. (2018), including the
possibility of reverse causation due to the timing of urine collection,
should be considered. Although our maternal preconception BPA and
BPS findings could be compatible with the abovementioned studies,
differences between the preconception and prenatal windows preclude
additional comparisons.
In the present study, maternal preconception exposure to bisphenols
appeared to influence the risk of preterm birth. Although mechanistic
data on preconception environmental exposures is markedly scarce, this
latent effect is compatible with the known ability of BPA to alter the
epigenetic programming of the ovary and other reproductive tissues
including the uterus and placenta (Santangeli et al., 2017; Suvorov and
Waxman, 2015; Ye et al., 2019). Indeed, BPA was recently highlighted
as an example of a female reproductive toxicant that may act through
epigenetic mechanisms (Luderer et al., 2019). In support of our novel
maternal preconception BPS-preterm birth association, a recent in vivo
study has shown that BPS can also exert epigenetic modifications in
oocytes at very low doses, resulting in altered female reproductive
outcomes such as decreased fertilization rates (Nevoral et al., 2018).
Additionally, two murine-model studies support the existence of
transgenerational female reproductive effects in response to low-dose
BPS exposure during gestation (Shi et al., 2019b, 2019a). Our results
Table 4
Risk Ratios (RR) and 95% Confidence Intervals (95% Cis) for preterm birth (< 37 weeks) per natural log-unit increase in paternal preconception urinary phenol











Covariates + Prenatal c
Preterm Birth
Model 4
Covariates + Maternal Precon d
RR (95% CI) RR (95% CI) RR (95% CI) RR (95% CI)
Bisphenol A
0.95 (0.52, 1.74) 0.82 (0.43, 1.55) 0.82 (0.41, 1.65) 0.69 (0.35, 1.37)
p-values 0.86 0.54 0.58 0.29
Preterm Birth n/N 18/229 18/229 17/213 18/228
Bisphenol S
0.49 (0.08, 2.98) DNC DNC DNC
p-values 0.44
Preterm Birth n/N 2/77 2/77 1/68 2/74
∑Parabense
1.27 (0.90, 1.77) 1.36 (0.94, 1.96) 1.39 (0.95, 2.04) 1.42 (0.97, 2.09)
p-values 0.17 0.10 0.09 0.07
Preterm Birth n/N 18/223 18/223 17/207 17/221
Benzophenone-3
1.01 (0.58, 1.73) 1.02 (0.53, 1.99) 0.92 (0.44, 1.94) 0.81 (0.39, 1.69)
p-values 0.98 0.95 0.83 0.58
Preterm Birth n/N 8/139 8/139 7/128 8/137
Triclosan
0.98 (0.67, 1.42) 0.97 (0.67, 1.41) 1.07 (0.59, 1.93) 0.86 (0.51, 1.46)
p-values 0.90 0.88 0.82 0.58
Preterm Birth n/N 8/139 8/139 7/128 8/137
Note: n, number of preterm birth cases; N, sample size for paternal preconception biomarker concentrations; DNC, did not converge; Precon, maternal preconception.
a Models 1: Unadjusted.
b Models 2: Adjusted for maternal and paternal age (continuous), maternal and paternal BMI (continuous), ART (yes/no), maternal and paternal smoking (ever/
never), education (categorical).
c Models 3: Adjusted for maternal and paternal age (continuous), maternal and paternal BMI (continuous), ART (yes/no), maternal and paternal smoking (ever/
never), education (categorical) + prenatal biomarker exposure (continuous log-concentration).
d Models 4: Adjusted for maternal and paternal age (continuous), maternal and paternal BMI (continuous), ART (yes/no), maternal and paternal smoking (ever/
never), education (categorical) + maternal preconception biomarker exposure (continuous log-concentration).
e ΣParabens: the molar sum of parabens was estimated by dividing each concentration by its molecular weight and then summing: ∑Parabens = [(Methylparaben
* (1/152.15)) + (Propylparaben * (1/180.20)) + (Butylparaben * (1/194.23))]. We then weighted this sum by the molecular weight of methylparaben (152.15) to
convert the molar concentration to units of ng/ml.
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are consistent with the increasing evidence that suggests similar or even
stronger reprotoxic effects of BPS compared to BPA (Campen et al.,
2018; Trasande, 2017; Žalmanová et al., 2017).
We previously observed that maternal preconception urinary BPA
concentrations were inversely associated with offspring birth size in
this same cohort (Mustieles et al., 2018). Our hypothesis of an early
potential effect in the ovary, affecting oocyte quality and later resulting
in reduced embryo viability and development and/or altered placental
function leading to impaired fetal growth (Mustieles et al., 2018) is
further supported by these preterm birth data. Importantly, such ad-
verse pregnancy processes are also converging risk factors for preterm
birth (Delnord and Zeitlin, 2019), which could have its roots in the
early pre- and peri-conception period.
Although we observed that paternal paraben concentrations were
associated with preterm birth, no previous epidemiologic reports with
which to compare our results are available. However, in support of a
potential association, parabens have been reported to increase oxida-
tive stress in human spermatozoa (Samarasinghe et al., 2018), and
butylparaben altered sperm DNA methylation in rats (Park et al., 2012).
Some epidemiologic studies have reported associations between
paraben exposure and altered semen quality (Zamkowska et al., 2018),
while research from our own group in a smaller subsample of men did
not (Meeker et al., 2011). Mechanistic studies evaluating the potential
ability of parabens to exert heritable epigenetic modifications in sper-
matozoa could shed light on this field of study. Additional epidemio-
logic studies are needed to confirm or rule out the observed paternal
associations with methyl- and propylparaben.
The absence of consistent preconception associations with benzo-
phenone-3 and triclosan in our study may be compatible with previous
mother–child cohorts assessing exposure during pregnancy, with most
studies reporting inconsistencies. For example, null associations be-
tween prenatal urinary benzophenone-3 concentrations and preterm
birth were observed among North-American women, while finding a
protective association in response to higher urinary triclosan con-
centrations (Aung et al., 2019). Another study in Chinese pregnant
women who provided a spot urine sample upon hospital admission for
delivery found that benzophenone-3 concentrations were negatively
associated with gestational age (Tang et al., 2013). In contrast, Aker
et al. (2019) reported positive associations between maternal prenatal
urinary benzophenone-3 concentrations and gestational age among
Puerto Rican women, while triclosan concentrations were positively
associated with gestational age in males, but negatively associated in
females (Aker et al., 2019). Finally, Huo et al. (2018) did not observe
associations of prenatal urinary triclosan concentrations and preterm
birth risk among Chinese mothers (Huo et al., 2018). The considerable
heterogeneity in these findings may be due to differences in exposure
definition and measurement (e.g., gestational age at time of prenatal
urine sample collection), variations in study populations, the evaluation
vs. lack of evaluation of sex-dependent associations, or other differences
in methods.
A strength of this study was the opportunity to assess both maternal
and paternal exposure prior to conception, accounting for relevant
potential confounders (Bellavia et al., 2019). Indeed, to our knowledge,
this is the first work to examine phenol exposure in the preconception
period in relation to the risk of preterm birth. Our findings may not be
directly generalizable to fertile couples since subfertile mothers and
fathers could be more susceptible to environmental insults. Notwith-
standing, our results are consistent with previous studies reporting BPA-
related adverse pregnancy outcomes in both subfertile and non-sub-
fertile preconception cohorts (Mustieles et al., 2018; Smarr et al.,
2015). Another strength is the ongoing follow-up of the EARTH Study,
which allowed for a timely assessment of exposure to new chemical
replacements such as BPS. BPS is suspected of causing similar re-
protoxic effects as BPA, but has not undergone an exhaustive tox-
icological examination before its use in consumer goods (Trasande,
2017). Additionally, the assessment of diverse phenolic EDCs using
multiple repeated urine samples allowed for improved exposure as-
sessment thereby reducing exposure misclassification and its expected
attenuation bias (Perrier et al., 2016). Nevertheless, some degree of
exposure misclassification cannot be ruled out considering the short
biological half-lives and episodic nature of exposure to these non-per-
sistent chemicals. While a limitation was the modest number of preterm
birth cases, which precluded us from studying preterm birth subtypes
(i.e., spontaneous preterm labor, preterm premature rupture of mem-
branes, placental abruption, etc.), this is one of the few studies in the
field that has examined preterm birth risk under a prospective pre-
conception cohort design. As we were not powered for estimating effect
modification, small sample size within strata may have limited our
ability to detect differences by infant sex. Future analyses with a higher
number of male participants are warranted to confirm the reported
associations with paternal preconception paraben exposure.
5. Conclusion
Maternal preconception urinary BPA and BPS concentrations as well
as paternal preconception urinary paraben concentrations were pro-
spectively associated with an increased risk of preterm birth. Our re-
sults suggest that couples’ exposure to select phenols during pre-
conception, especially exposure to bisphenols, is an overlooked risk
factor for adverse pregnancy outcomes. These findings may have sig-
nificant public health implications given the importance of the out-
come, the ubiquity of BPA exposure, its regrettable substitution with
BPS and other structural analogs with similar reprotoxic potential, and
that prevention strategies are needed to advance preconception care.
While future studies should validate these associations, it may be pru-
dent to inform couples planning conception about measures to reduce
EDC exposure.
6. Disclaimer
The findings and conclusions in this report are those of the authors
and do not necessarily represent the official position of the Centers for
Disease Control and Prevention (CDC). Use of trade names is for iden-
tification only and does not imply endorsement by the CDC, the Public
Health Service, or the US Department of Health and Human Services.
7. Funding information
Work supported by grants ES009718 and ES000002 from the
National Institute of Environmental Health Sciences (NIEHS). C.M. re-
ceived funding from the Canadian Institutes of Health Research.
CRediT authorship contribution statement
Vicente Mustieles: Conceptualization, Methodology, Writing -
original draft, Writing - review & editing. Yu Zhang: Software, Formal
analysis, Validation, Visualization, Writing - review & editing. Jennifer
Yland: Writing - review & editing. Joseph M. Braun: Writing - review
& editing. Paige L. Williams: Methodology, Writing - review & editing.
Blair J. Wylie: Writing - review & editing. Jill A. Attaman: Writing -
review & editing. Jennifer B. Ford: Project administration, Resources.
Alexandra Azevedo: Project administration. Antonia M. Calafat:
Writing - review & editing, Data curation. Russ Hauser: Writing - re-
view & editing, Funding acquisition. Carmen Messerlian:
Conceptualization, Methodology, Formal analysis, Writing - original
draft, Writing - review & editing, Supervision.
Declaration of Competing Interest
The authors declare that they have no known competing financial
interests or personal relationships that could have appeared to influ-
ence the work reported in this paper.
V. Mustieles, et al. Environment International 137 (2020) 105523
7
Acknowledgments
The authors acknowledge all members of the EARTH Study team,
including research staff Ramace Dadd and Myra Keller, and physicians
and staff at Massachusetts General Hospital Fertility Center. We are also
grateful to all study participants. The authors also gratefully acknowl-
edge Xiaoliu Zhou, Tao Jia, and the late Xiaoyun Ye (CDC, Atlanta, GA)
for measuring the urinary concentrations of phenol biomarkers.
Appendix A. Supplementary material
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2020.105523.
References
ACOG, 2014. Committee opinion no 611: method for estimating due date. Obstet.
Gynecol. 124, 863–6. https://doi.org/10.1097/01.AOG.0000454932.15177.be.
Aker, A.M., Ferguson, K.K., Rosario, Z.Y., Mukherjee, B., Alshawabkeh, A.N., Cordero,
J.F., Meeker, J.D., 2019. The associations between prenatal exposure to triclocarban,
phenols and parabens with gestational age and birth weight in northern Puerto Rico.
Environ. Res. 169, 41–51. https://doi.org/10.1016/j.envres.2018.10.030.
Aung, M.T., Ferguson, K.K., Cantonwine, D.E., McElrath, T.F., Meeker, J.D., 2019.
Preterm birth in relation to the bisphenol A replacement, bisphenol S, and other
phenols and parabens. Environ. Res. 169, 131–138. https://doi.org/10.1016/j.
envres.2018.10.037.
Behnia, F., Peltier, M., Getahun, D., Watson, C., Saade, G., Menon, R., 2016. High bi-
sphenol A (BPA) concentration in the maternal, but not fetal, compartment increases
the risk of spontaneous preterm delivery. J. Matern. Neonatal Med. 29, 3583–3589.
https://doi.org/10.3109/14767058.2016.1139570.
Bellavia, A., Mitro, S.D., Hauser, R., James-Todd, T., 2019. Paternal bias: the impact of
not accounting for paternal confounders in reproductive epidemiological studies. Am.
J. Obstet. Gynecol. https://doi.org/10.1016/j.ajog.2019.08.005.
Braun, J.M., Messerlian, C., Hauser, R., 2017. Fathers matter: why it’s time to consider the
impact of paternal environmental exposures on children’s health. Curr. Epidemiol.
Reports 4, 46–55. https://doi.org/10.1007/s40471-017-0098-8.
Buckley, J.P., Doherty, B.T., Keil, A.P., Engel, S.M., 2017. Statistical approaches for es-
timating sex-specific effects in endocrine disruptors research. Environ. Health
Perspect. 125, 067013. https://doi.org/10.1289/EHP334.
Campen, K.A., Kucharczyk, K.M., Bogin, B., Ehrlich, J.M., Combelles, C.M.H., 2018.
Spindle abnormalities and chromosome misalignment in bovine oocytes after ex-
posure to low doses of bisphenol A or bisphenol S. Hum. Reprod. 33, 895–904.
https://doi.org/10.1093/humrep/dey050.
Cantonwine, D., Meeker, J.D., Hu, H., Sánchez, B.N., Lamadrid-Figueroa, H., Mercado-
García, A., Fortenberry, G.Z., Calafat, A.M., Téllez-Rojo, M.M., 2010. Bisphenol a
exposure in Mexico city and risk of prematurity: a pilot nested case control study.
Environ. Heal. 9, 62. https://doi.org/10.1186/1476-069X-9-62.
Cantonwine, D.E., Ferguson, K.K., Mukherjee, B., McElrath, T.F., Meeker, J.D., 2015.
Urinary bisphenol a levels during pregnancy and risk of preterm birth. Environ.
Health Perspect. 123, 895–901. https://doi.org/10.1289/ehp.1408126.
Carvaillo, J.-C., Barouki, R., Coumoul, X., Audouze, K., 2019. Linking bisphenol S to
adverse outcome pathways using a combined text mining and systems biology ap-
proach. Environ. Health Perspect. 127, 047005. https://doi.org/10.1289/EHP4200.
Chawanpaiboon, S., Vogel, J.P., Moller, A.-B., Lumbiganon, P., Petzold, M., Hogan, D.,
Landoulsi, S., Jampathong, N., Kongwattanakul, K., Laopaiboon, M., Lewis, C.,
Rattanakanokchai, S., Teng, D.N., Thinkhamrop, J., Watananirun, K., Zhang, J.,
Zhou, W., Gülmezoglu, A.M., 2019. Global, regional, and national estimates of levels
of preterm birth in 2014: a systematic review and modelling analysis. Lancet. Glob.
Heal. 7, e37–e46. https://doi.org/10.1016/S2214-109X(18)30451-0.
Delnord, M., Zeitlin, J., 2019. Epidemiology of late preterm and early term births – an
international perspective. Semin. Fetal Neonatal Med. 24, 3–10. https://doi.org/10.
1016/j.siny.2018.09.001.
ECHA, 2016. ECHA. Member State Committee Support Document for Identification of 4,
4’-Isopropylidenediphenol (Bisphenol A) as a Substance of Very High Concern
Because of its Toxic For Reproduction (Article 57 C), EC 201-245-8, CAS 80-05-7.
EFCNI, 2010. Too little, too late? Why Europe should do more for preterm infants.
https://www.efcni.org/wp-content/uploads/2018/03/EFCNI_report_light_copyright.
pdf (accessed 6.18.19).
Ferguson, K.K., Chin, H.B., 2017. Environmental chemicals and preterm birth: Biological
mechanisms and the state of the science. Curr. Epidemiol. Rep. 4, 56–71. https://doi.
org/10.1007/s40471-017-0099-7.
Ferguson, K.K., Colacino, J.A., Lewis, R.C., Meeker, J.D., 2017. Personal care product use
among adults in NHANES: associations between urinary phthalate metabolites and
phenols and use of mouthwash and sunscreen. J. Expo. Sci. Environ. Epidemiol. 27,
326–332. https://doi.org/10.1038/jes.2016.27.
Frederiksen, H., Jensen, T.K., Jørgensen, N., Kyhl, H.B., Husby, S., Skakkebæk, N.E.,
Main, K.M., Juul, A., Andersson, A.-M., 2014. Human urinary excretion of non-per-
sistent environmental chemicals: an overview of Danish data collected between 2006
and 2012. Reproduction 147, 555–565. https://doi.org/10.1530/REP-13-0522.
Freire, C., Molina-Molina, J.-M., Iribarne-Durán, L.M., Jiménez-Díaz, I., Vela-Soria, F.,
Mustieles, V., Arrebola, J.P., Fernández, M.F., Artacho-Cordón, F., Olea, N., 2019.
Concentrations of bisphenol A and parabens in socks for infants and young children
in Spain and their hormone-like activities. Environ. Int. 127, 592–600. https://doi.
org/10.1016/j.envint.2019.04.013.
Ghazipura, M., McGowan, R., Arslan, A., Hossain, T., 2017. Exposure to benzophenone-3
and reproductive toxicity: a systematic review of human and animal studies. Reprod.
Toxicol. 73, 175–183. https://doi.org/10.1016/j.reprotox.2017.08.015.
Giulivo, M., Lopez de Alda, M., Capri, E., Barceló, D., 2016. Human exposure to endocrine
disrupting compounds: their role in reproductive systems, metabolic syndrome and
breast cancer a review. Environ. Res. 151, 251–264. https://doi.org/10.1016/j.
envres.2016.07.011.
Hornung, R.L., 1990. Estimation of average concentration in the presence of non-
detectable values. Appl. Ocuupational Environ. Hyg. 5, 46–51.
Huo, W., Xia, W., Wu, C., Zhu, Y., Zhang, B., Wan, Y., Zhou, A., Qian, Z., Chen, Z., Jiang,
Y., Liu, H., Hu, J., Xu, B., Xu, S., Li, Y., 2018. Urinary level of triclosan in a population
of Chinese pregnant women and its association with birth outcomes. Environ. Pollut.
233, 872–879. https://doi.org/10.1016/j.envpol.2017.08.073.
Jamal, A., Rastkari, N., Dehghaniathar, R., Aghaei, M., Nodehi, R.N., Nasseri, S., Kashani,
H., Yunesian, M., 2019. Prenatal exposure to parabens and anthropometric birth
outcomes: a systematic review. Environ. Res. 173, 419–431. https://doi.org/10.
1016/j.envres.2019.02.044.
Johnson, P.I., Koustas, E., Vesterinen, H.M., Sutton, P., Atchley, D.S., Kim, A.N.,
Campbell, M., Donald, J.M., Sen, S., Bero, L., Zeise, L., Woodruff, T.J., 2016.
Application of the navigation guide systematic review methodology to the evidence
for developmental and reproductive toxicity of triclosan. Environ. Int. 92–93,
716–728. https://doi.org/10.1016/j.envint.2016.03.009.
Kataria, A., Levine, D., Wertenteil, S., Vento, S., Xue, J., Rajendiran, K., Kannan, K.,
Thurman, J.M., Morrison, D., Brody, R., Urbina, E., Attina, T., Trasande, L.,
Trachtman, H., 2017. Exposure to bisphenols and phthalates and association with
oxidant stress, insulin resistance, and endothelial dysfunction in children. Pediatr.
Res. 81, 857–864. https://doi.org/10.1038/pr.2017.16.
Liao, C., Kannan, K., 2014. Widespread occurrence of benzophenone-type UV light filters
in personal care products from China and the United States: an assessment of human
exposure. Environ. Sci. Technol. 48, 4103–4109. https://doi.org/10.1021/
es405450n.
Luderer, U., Eskenazi, B., Hauser, R., Korach, K.S., McHale, C.M., Moran, F., Rieswijk, L.,
Solomon, G., Udagawa, O., Zhang, L., Zlatnik, M., Zeise, L., Smith, M.T., 2019.
Proposed key characteristics of female reproductive toxicants as an approach for
organizing and evaluating mechanistic data in hazard assessment. Environ. Health
Perspect. 127, 75001. https://doi.org/10.1289/EHP4971.
Mani, S., Ghosh, J., Lan, Y., Senapati, S., Ord, T., Sapienza, C., Coutifaris, C., Mainigi, M.,
2018. Epigenetic changes in preterm birth placenta suggest a role for ADAMTS genes
in spontaneous preterm birth. Hum. Mol. Genet. 28, 84–95. https://doi.org/10.1093/
hmg/ddy325.
Meeker, J.D., Yang, T., Ye, X., Calafat, A.M., Hauser, R., 2011. Urinary concentrations of
parabens and serum hormone levels, semen quality parameters, and sperm DNA
damage. Environ. Health Perspect. 119, 252–257. https://doi.org/10.1289/ehp.
1002238.
Menon, R., Conneely, K.N., Smith, A.K., 2012. DNA methylation: an epigenetic risk factor
in preterm birth. Reprod. Sci. 19, 6–13. https://doi.org/10.1177/
1933719111424446.
Messerlian, C., Mustieles, V., Minguez-Alarcon, L., Ford, J.B., Calafat, A.M., Souter, I.,
Williams, P.L., Hauser, R., 2018a. Preconception and prenatal urinary concentrations
of phenols and birth size of singleton infants born to mothers and fathers from the
environment and reproductive health (EARTH) study. Environ. Int. 114. https://doi.
org/10.1016/j.envint.2018.02.017.
Messerlian, C., Mustieles, V., Wylie, B.J., Ford, J.B., Keller, M., Ye, X., Calafat, A.M.,
Williams, P.L., Hauser, R., Environment Team Reproductive Health Study, 2017.
Ultrasound gel as an unrecognized source of exposure to phthalates and phenols
among pregnant women undergoing routine scan. Int. J. Hyg. Environ. Health 220,
1285–1294. https://doi.org/10.1016/j.ijheh.2017.08.003.
Messerlian, C., Williams, P.L., Ford, J.B., Chavarro, J.E., Mínguez-Alarcón, L., Dadd, R.,
Braun, J.M., Gaskins, A.J., Meeker, J.D., James-Todd, T., Chiu, Y.-H., Nassan, F.L.,
Souter, I., Petrozza, J., Keller, M., Toth, T.L., Calafat, A.M., Hauser, R., 2018b. The
environment and reproductive health (EARTH) study: a prospective preconception
cohort. Hum. Reprod. Open 1–11. https://doi.org/10.1093/hropen/hoy001.
Mínguez-Alarcón, L., Messerlian, C., Bellavia, A., Gaskins, A.J., Chiu, Y.H., Ford, J.B.,
Azevedo, A.R., Petrozza, J.C., Calafat, A.M., Hauser, R., Williams, P.L., 2019. Urinary
concentrations of bisphenol A, parabens and phthalate metabolite mixtures in rela-
tion to reproductive success among women undergoing in vitro fertilization. Environ.
Int. 126, 355–362. https://doi.org/10.1016/j.envint.2019.02.025.
Molina-Molina, J.M., Jiménez-Díaz, I., Fernández, M.F., Rodriguez-Carrillo, A., Peinado,
F.M., Mustieles, V., Barouki, R., Piccoli, C., Olea, N., Freire, C., 2019. Determination
of bisphenol A and bisphenol S concentrations and assessment of estrogen- and anti-
androgen-like activities in thermal paper receipts from Brazil, France, and Spain.
Environ. Res. 170, 406–415. https://doi.org/10.1016/j.envres.2018.12.046.
Mustieles, V., Pérez-Lobato, R., Olea, N., Fernández, M.F., 2015. Bisphenol A: Human
exposure and neurobehavior. Neurotoxicology. https://doi.org/10.1016/j.neuro.
2015.06.002.
Mustieles, V., Williams, P.L., Fernandez, M.F., Mínguez-Alarcón, L., Ford, J.B., Calafat,
A.M., Hauser, R., Messerlian, C., 2018. Maternal and paternal preconception ex-
posure to bisphenols and size at birth. Hum. Reprod. 33, 1528–1537. https://doi.org/
10.1093/humrep/dey234.
Nevoral, J., Kolinko, Y., Moravec, J., Žalmanová, T., Hošková, K., Prokešová, Š., Klein, P.,
Ghaibour, K., Hošek, P., Štiavnická, M., Řimnáčová, H., Tonar, Z., Petr, J., Králíčková,
M., 2018. Long-term exposure to very low doses of bisphenol S affects female re-
production. Reproduction 156, 47–57. https://doi.org/10.1530/REP-18-0092.
V. Mustieles, et al. Environment International 137 (2020) 105523
8
Nowak, K., Ratajczak-Wrona, W., Górska, M., Jabłońska, E., 2018. Parabens and their
effects on the endocrine system. Mol. Cell. Endocrinol. 474, 238–251. https://doi.
org/10.1016/j.mce.2018.03.014.
Park, C.J., Nah, W.H., Lee, J.E., Oh, Y.S., Gye, M.C., 2012. Butyl paraben-induced changes
in DNA methylation in rat epididymal spermatozoa. Andrologia 44, 187–193.
https://doi.org/10.1111/j.1439-0272.2011.01162.x.
Pearson, M.A., Lu, C., Schmotzer, B.J., Waller, L.A., Riederer, A.M., 2009. Evaluation of
physiological measures for correcting variation in urinary output: implications for
assessing environmental chemical exposure in children. J. Expo. Sci. Environ.
Epidemiol. 19, 336–342. https://doi.org/10.1038/jes.2008.48.
Peretz, J., Vrooman, L., Ricke, W.A., Hunt, P.A., Ehrlich, S., Hauser, R., Padmanabhan, V.,
Taylor, H.S., Swan, S.H., VandeVoort, C.A., Flaws, J.A., 2014. Bisphenol a and re-
productive health: update of experimental and human evidence, 2007–2013.
Environ. Health Perspect. 122, 775–786. https://doi.org/10.1289/ehp.1307728.
Perrier, F., Giorgis-Allemand, L., Slama, R., Philippat, C., 2016. Within-subject pooling of
biological samples to reduce exposure misclassification in biomarker-based studies.
Epidemiology 27, 378–388. https://doi.org/10.1097/EDE.0000000000000460.
Porpora, M., Piacenti, I., Scaramuzzino, S., Masciullo, L., Rech, F., Benedetti Panici, P.,
2019. Environmental contaminants exposure and preterm birth: a systematic review.
Toxics 7, 11. https://doi.org/10.3390/toxics7010011.
Rochester, J.R., Bolden, A.L., 2015. Bisphenol S and F: A systematic review and com-
parison of the hormonal activity of bisphenol a substitutes. Environ. Health Perspect.
123, 643–650. https://doi.org/10.1289/ehp.1408989.
Romero, R., Dey, S.K., Fisher, S.J., 2014. Preterm labor: one syndrome, many causes.
Science 345 (80), 760–765. https://doi.org/10.1126/science.1251816.
Rosenfeld, C.S., 2015. Sex-specific placental responses in fetal development.
Endocrinology. https://doi.org/10.1210/en.2015-1227.
Rubens, C.E., Sadovsky, Y., Muglia, L., Gravett, M.G., Lackritz, E., Gravett, C., 2014.
Prevention of preterm birth: Harnessing science to address the global epidemic. Sci.
Transl. Med. https://doi.org/10.1126/scitranslmed.3009871.
Samarasinghe, S.V.A.C., Krishnan, K., Naidu, R., Megharaj, M., Miller, K., Fraser, B.,
Aitken, R.J., 2018. Parabens generate reactive oxygen species in human spermatozoa.
Andrology 6, 532–541. https://doi.org/10.1111/andr.12499.
Santangeli, S., Maradonna, F., Olivotto, I., Piccinetti, C.C., Gioacchini, G., Carnevali, O.,
2017. Effects of BPA on female reproductive function: The involvement of epigenetic
mechanism. Gen. Comp. Endocrinol. 245, 122–126. https://doi.org/10.1016/j.ygcen.
2016.08.010.
Savitz, D.A., Terry, J.W., Dole, N., Thorp, J.M., Siega-Riz, A.M., Herring, A.H., 2002.
Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and
their combination. Am. J. Obstet. Gynecol. 187, 1660–1666. https://doi.org/10.
1067/mob.2002.127601.
Shi, M., Sekulovski, N., MacLean, J.A., Whorton, A., Hayashi, K., 2019a. Prenatal ex-
posure to bisphenol a analogues on female reproductive functions in mice. Toxicol.
Sci. 168, 561–571. https://doi.org/10.1093/toxsci/kfz014.
Shi, M., Whorton, A.E., Sekulovski, N., MacLean, J.A., Hayashi, K., 2019b. Prenatal ex-
posure to bisphenol A, E and S induces transgenerational effects on female re-
productive functions in mice. Toxicol. Sci. https://doi.org/10.1093/toxsci/kfz124.
Smarr, M.M., Grantz, K.L., Sundaram, R., Maisog, J.M., Kannan, K., Louis, G.M.B., 2015.
Parental urinary biomarkers of preconception exposure to bisphenol A and phthalates
in relation to birth outcomes. Environ. Heal. 14, 73. https://doi.org/10.1186/
s12940-015-0060-5.
Suvorov, A., Waxman, D.J., 2015. Early programing of uterine tissue by bisphenol a:
critical evaluation of evidence from animal exposure studies. Reprod. Toxicol. 57,
59–72. https://doi.org/10.1016/j.reprotox.2015.05.008.
Tang, R., Chen, M., Ding, G., Chen, X., Han, X., Zhou, K., Chen, L., Xia, Y., Tian, Y., Wang,
X., 2013. Associations of prenatal exposure to phenols with birth outcomes. Environ.
Pollut. 178, 115–120. https://doi.org/10.1016/j.envpol.2013.03.023.
Textor, J., van der Zander, B., Gilthorpe, M.S., Liskiewicz, M., Ellison, G.T., 2016. Robust
causal inference using directed acyclic graphs: the R package “dagitty”. Int. J.
Epidemiol. 45, 1887–1894. https://doi.org/10.1093/ije/dyw341.
Toivonen, K.I., Oinonen, K.A., Duchene, K.M., 2017. Preconception health behaviours: a
scoping review. Prev. Med. (Baltim) 96, 1–15. https://doi.org/10.1016/j.ypmed.
2016.11.022.
Trasande, L., 2017. Exploring regrettable substitution: replacements for bisphenol A.
Lancet. Planet. Heal. 1, e88–e89. https://doi.org/10.1016/S2542-5196(17)30046-3.
Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs, D.R., Lee, D.-H., Shioda,
T., Soto, A.M., vom Saal, F.S., Welshons, W.V., Zoeller, R.T., Myers, J.P., 2012.
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic
dose responses. Endocr. Rev. 33, 378–455. https://doi.org/10.1210/er.2011-1050.
Vandenberg, L.N., Hauser, R., Marcus, M., Olea, N., Welshons, W.V., 2007. Human ex-
posure to bisphenol A (BPA). Reprod. Toxicol. 24, 139–177. https://doi.org/10.
1016/j.reprotox.2007.07.010.
von Goetz, N., Pirow, R., Hart, A., Bradley, E., Poças, F., Arcella, D., Lillegard, I.T.L.,
Simoneau, C., van Engelen, J., Husoy, T., Theobald, A., Leclercq, C., 2017. Including
non-dietary sources into an exposure assessment of the European food safety au-
thority: the challenge of multi-sector chemicals such as bisphenol A. Regul. Toxicol.
Pharm. 85, 70–78. https://doi.org/10.1016/j.yrtph.2017.02.004.
Wan, Y., Huo, W., Xu, S., Zheng, T., Zhang, B., Li, Y., Zhou, A., Zhang, Y., Hu, J., Zhu, Y.,
Chen, Z., Lu, S., Wu, C., Jiang, M., Jiang, Y., Liu, H., Yang, X., Xia, W., 2018.
Relationship between maternal exposure to bisphenol S and pregnancy duration.
Environ. Pollut. 238, 717–724. https://doi.org/10.1016/j.envpol.2018.03.057.
WHO, 2012. The Global Action Report on Preterm Birth Born Too Soon. https://apps.
who.int/iris/bitstream/handle/10665/44864/9789241503433_eng.pdf?sequence=
1 (accessed 6.18.19).
Wu, L.-H., Zhang, X.-M., Wang, F., Gao, C.-J., Chen, D., Palumbo, J.R., Guo, Y., Zeng, E.Y.,
2018. Occurrence of bisphenol S in the environment and implications for human
exposure: a short review. Sci. Total Environ. 615, 87–98. https://doi.org/10.1016/j.
scitotenv.2017.09.194.
Xin, F., Susiarjo, M., Bartolomei, M.S., 2015. Multigenerational and transgenerational
effects of endocrine disrupting chemicals: a role for altered epigenetic regulation?
Semin. Cell Dev. Biol. 43, 66–75. https://doi.org/10.1016/j.semcdb.2015.05.008.
Ye, X., Wong, L.-Y., Kramer, J., Zhou, X., Jia, T., Calafat, A.M., 2015. Urinary con-
centrations of bisphenol a and three other bisphenols in convenience samples of U.S.
adults during 2000–2014. Environ. Sci. Technol. 49, 11834–11839. https://doi.org/
10.1021/acs.est.5b02135.
Ye, Y., Tang, Y., Xiong, Y., Feng, L., Li, X., 2019. Bisphenol A exposure alters placentation
and causes preeclampsia-like features in pregnant mice involved in reprogramming of
DNA methylation of WNT2. FASEB J. 33, 2732–2742. https://doi.org/10.1096/fj.
201800934RRR.
Žalmanová, T., Hošková, K., Nevoral, J., Adámková, K., Kott, T., Šulc, M., Kotíková, Z.,
Prokešová, Š., Jílek, F., Králíčková, M., Petr, J., 2017. Bisphenol S negatively affects
the meotic maturation of pig oocytes. Sci. Rep. 7, 485. https://doi.org/10.1038/
s41598-017-00570-5.
Zama, A.M., Uzumcu, M., 2010. Epigenetic effects of endocrine-disrupting chemicals on
female reproduction: An ovarian perspective. Front. Neuroendocrinol. 31, 420–439.
https://doi.org/10.1016/j.yfrne.2010.06.003.
Zamkowska, D., Karwacka, A., Jurewicz, J., Radwan, M., 2018. Environmental exposure
to non-persistent endocrine disrupting chemicals and semen quality: an overview of
the current epidemiological evidence. Int. J. Occup. Med. Environ. Health 31,
377–414. https://doi.org/10.13075/ijomeh.1896.01195.
Zhou, X., Kramer, J.P., Calafat, A.M., Ye, X., 2014. Automated on-line column-switching
high performance liquid chromatography isotope dilution tandem mass spectrometry
method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other
phenols in urine. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 944, 152–156.
https://doi.org/10.1016/j.jchromb.2013.11.009.
Zoeller, R.T., Brown, T.R., Doan, L.L., Gore, A.C., Skakkebaek, N.E., Soto, A.M., Woodruff,
T.J., Vom Saal, F.S., 2012. Endocrine-disrupting chemicals and public health pro-
tection: a statement of principles from the endocrine society. Endocrinology 153,
4097–4110. https://doi.org/10.1210/en.2012-1422.
V. Mustieles, et al. Environment International 137 (2020) 105523
9
